Cytochrome P450 2D6 as a model antigen

Digestive Diseases

Volumn 28, Issue 1, 2010, Pages 80-85

  Christen, Urs ^a   Holdener, Martin ^a   Hintermann, Edith ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Autoimmune hepatitis; Molecular mimicry; Mouse model

Indexed keywords

CYTOCHROME P450 2D6; EPITOPE; LIVER KIDNEY MICROSOMAL ANTIBODY 1; MICROSOME ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL INTERACTION; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; IMMUNOLOGICAL TOLERANCE; LIVER FIBROSIS; LIVER INJURY; LYMPHOCYTE COUNT; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURAL HOMOLOGY; TRANSGENIC MOUSE; WILD TYPE;

ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; ANTIGENS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOCHROME P-450 CYP2D6; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; LIVER; MICE; MICE, TRANSGENIC; MOLECULAR MIMICRY;

EID: 77952561310     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282068     Document Type: Article

References (37)

1. Christen U, Hintermann E, Jaeckel E: New animal models for autoimmune hepatitis. Semin Liver Dis 2009;29:262-272.
2. Jaeckel E: Old and new animal models of AIH;in Manns MP, Lehnert H, Lohse AW (eds): Falk Liver Conference - Immunology and Liver Disease. Basel, Karger, 2009, p 171.
3. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF: Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989;83:1066-1072.
4. Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA: Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 1988;85:8256-8260.
5. Imaoka S, Obata N, Hiroi T, Osada-Oka M, Hara R, Nishiguchi S, Funae Y: A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from Japanese patients with autoimmune hepatitis. Biol Pharm Bull 2005;28:2240-2243.
6. Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D: Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003;170:1481-1489.
7. Klein R, Zanger UM, Berg T, Hopf U, Berg PA: Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol 1999;118:290-297.
8. Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-1378.
9. Sugimura T, Obermayer-Straub P, Kayser A, Braun S, Loges S, Alex B, Luttig B, Johnson EF, Manns MP, Strassburg CP: A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens. Autoimmunity 2002;35:501-513.
10. Yamamoto AM, Cresteil D, Boniface O, Clerc FF, Alvarez F: Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol 1993;23:1105-1111.
11. Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Arenz M, Gerken G, Meyer zum Büschenfelde KH: Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 1996;24:1416-1421.
12. Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D: Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis ty pe 2. Gastroenterology 2006;130:868-882.
13. Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D: Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 2007;46:472-484.
14. Gueguen M, Boniface O, Bernard O, Clerc F, Cartwright T, A lvarez F: Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney micro-some antibody. J Autoimmun 1991;4:607-615.
15. Kitazawa E, Igarashi T, Kawaguchi N, Matsushima H, Kawashima Y, Hankins RW, Miyakawa H: Differences in anti-LKM-1 auto-antibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients. J Autoimmun 2001;17:243-249.
16. Manns MP, Vogel A: Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006;43:S132-S144.
17. Christen U, von Herrath MG: Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 2004;40:1113-1120.
18. Damian RT: Molecular mimicry: antigen sharing by parasite and host and its consequences. The American Naturalist 1964;98:129-149.
19. Oldstone MB: Molecular mimicry and immune-mediated diseases. FASEB J 1998;12:1255-1265.
20. Christen U, Herrath MG: Initiation of autoimmunity. Curr Opin Immunol 2004;16:759-767.
21. Münz C, Lünemann JD, Getts MT, Miller SD: Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 2009;9:246-258.
22. Ang CW, Jacobs BC, Laman JD: The Guil-lain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 2004;25:61-66.
23. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW: Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-920.
24. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Matsuura E, Coppel RL, Gershwin ME: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005;174:5874-5883.
25. Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH, Kurth MJ, Gershwin ME: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003;38:1250-1257.
26. Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME: Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008;48:531-540.
27. Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B, Malissen B, Zinkern agel R, Hengartner H: Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
28. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-331.
29. von Herrath MG, Dockter J, Oldstone MB: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a trans-genic model. Immunity 1994;1:231-242.
30. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK: T cell immunodom-inance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 2002;3:627-634.
31. Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG: A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004;114:1290-1298.
32. Christen U, Hintermann E, Holdener M, von Herrath MG: Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun 2010;34:38-44.
33. Blume N, Leonard J, Xu ZJ, Watanabe O, Remotti H, Fishman J: Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. Arch Biochem Biophys 2000;381:191-204.
34. McLaughlin LA, Dickmann LJ, Wolf CR, Henderson CJ: Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening. Drug Metab Dispos 2008;36:1322-1331.
35. Yu AM, Haining RL: Expression, purification, and characterization of mouse CYP2d22. Drug Metab Dispos 2006;34:1167-1174.
36. Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, Johnson EF, Gonzalez FJ, Pfeilschifter J, Manns MP, Herrath MG, Christen U: Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008;205:1409-1422.
37. Mamula MJ, Lin RH, Janeway CA Jr, Hardin JA: Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-795.